University of Virginia
University of Virginia
Charlottesville, Virginia, United States5 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Not applicable | 2026-07-31 | NCT05625659 | |
| Fitness-adapted, Pembrolizumab-based Therapy for Untreated Classical Hodgkin Lymphoma Patients 60 Years of Age and Above | classic Hodgkin lymphoma | Active, not recruiting | Phase 2 | 2026-05-14 | NCT05404945 | |
| Human Laboratory Study of Apremilast for Alcohol Use Disorder | Alcohol Use Disorder, Chemically-Induced Disorders, alcohol-related disorders, psychiatric disorder, substance-related disorder | Recruiting | Phase 2 | 2026-05-01 | NCT07325266 | |
| Study of Pembrolizumab Combined With Decitabine and Pralatrexate in PTCL and CTCL | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, T-cell non-Hodgkin lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mature T-cell and NK-cell non-Hodgkin lymphoma, neoplasm, primary cutaneous T-cell non-Hodgkin lymphoma | Active, not recruiting | Phase 1 | 2026-04-07 | NCT03240211 | |
| Randomized Phase IIB Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in PTCL | mature T-cell and NK-cell non-Hodgkin lymphoma | Recruiting | Phase 2 | 2026-01-21 | NCT04747236 |